Azura Ophthalmics
PrivateLast Round
Series C
Oct 22, 2020
Total Funding Raised
$37.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Azura Ophthalmics is a clinical-stage biopharmaceutical company developing a new class of Ophthalmic Keratolytics for the treatment of Meibomian gland dysfunction (MGD) and other ocular surface diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Azura Ophthalmics Comparables
Compare Azura Ophthalmics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novaliq | 84% | |
| Stuart Therapeutics, Inc. | 77% | |
| Aldeyra Therapeutics | 76% | |
Azura Ophthalmics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 22, 2020 | ||||
| Series B | Oct 10, 2017 | ||||
| Series A | Mar 11, 2014 |
Key People
Founding team and executive leadership
Azura Ophthalmics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ganot Capital | Series B, Series A, Series C |
| OrbiMed | Series B, Series C |
| TPG Biotech | Series B, Series C |
| Elron Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 5304% MoM, from 25 to 1.4K.
- May 1, 2025
Monthly visitors increased 77% MoM.
Azura Ophthalmics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Azura Ophthalmics's valuation, stock price, and market status.